A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.

Clinical Trial ID NCT00377637

Rank	Title	Journal	Year	PubWeight™‹?›
1	Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.	J Am Soc Nephrol	2009	5.02
2	Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.	N Engl J Med	2011	4.08
3	Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study.	Rheumatology (Oxford)	2009	1.48
4	Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.	Arthritis Care Res (Hoboken)	2010	1.02
5	Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.	Arthritis Rheum	2010	0.94
6	Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial.	Lupus	2012	0.79
7	Crossing the Atlantic: the Euro-Lupus Nephritis regimen in North America.	Arthritis Rheumatol	2015	0.76